Selection of rhinovirus 1A variants adapted for growth in mouse lung epithelial cells

Angela L Rasmussen1, Vincent R Racaniello

  • 1Department of Microbiology, University of Washington, Seattle, WA 98114, USA. arasmus@u.washington.edu

Virology
|September 28, 2011
PubMed

Insights

Researchers developed a mouse model for rhinovirus (RV) infection, the cause of the common cold. This new model, using adapted RV1A, will aid in studying RV pathogenesis and finding new treatments.

Area of Science:

  • Virology
  • Immunology
  • Respiratory Medicine

Background:

  • Rhinoviruses (RVs) are the primary cause of human upper respiratory tract infections, commonly known as the "common cold."
  • RVs can also lead to more severe conditions like pneumonia, asthma exacerbations, and complications in cystic fibrosis patients.
  • Current limitations exist due to the lack of suitable animal models for studying RV pathogenesis.

Purpose of the Study:

  • To develop a functional animal model for rhinovirus infection to study disease mechanisms.
  • To investigate the potential of adapted RV strains for use in a mouse model.
  • To identify potential therapeutic targets for rhinovirus-induced illnesses.

Main Methods:

  • Rhinovirus RV1A was adapted for improved replication in mouse embryonic fibroblasts and lung epithelial cells through serial passage.
  • Amino acid alterations in the non-structural protein 3A were identified as key to this adaptation.
  • Mouse model development involved productively infecting mice with adapted RV1A after chemical permeabilization of the airway.

Main Results:

  • Rhinovirus RV1A variants with enhanced replication in mouse cells were successfully generated.
  • Specific amino acid changes in RV1A protein 3A were crucial for improved mouse cell adaptation.
  • Adapted RV1A demonstrated productive infection in mice with a permeabilized airway.

Conclusions:

  • A novel mouse model for rhinovirus infection has been established.
  • This model provides a valuable tool for investigating rhinovirus pathogenesis and host response.
  • The developed model may facilitate the identification of new therapeutic strategies against rhinovirus infections.